SCHEMBL8947047

SCHEMBL8947047

CCCCc1ccc(-c2ccc(CCCI)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 6/20 0.56
HSD17B10 Q99714 3/20 0.50
TSHR P16473 2/20 0.50
ALDH1A1 P00352 3/20 0.49
MEN1 O00255 1/20 0.49
RARA P10276 1/20 0.49
MAPT P10636 1/20 0.49
MTOR P42345 1/20 0.49
KMT2A Q03164 1/20 0.49
CA2 P00918 2/20 0.48
CA1 P00915 1/20 0.48
HSD11B1 P28845 1/20 0.47
HPGD P15428 1/20 0.47
NISCH Q9Y2I1 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ESR1 P03372 2/20 0.45
ADRA2A P08913 2/20 0.45
ADORA3 P0DMS8 2/20 0.45
TACR2 P21452 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28829434 0.89 RARB (0.67) RARBHSD17B10TSHRALDH1A1MEN1
SCHEMBL5551587 0.89 RARB (0.67) RARBHSD17B10TSHRALDH1A1MEN1
SCHEMBL8500851 0.86 ALDH1A1 (0.54) RARBHSD17B10ALDH1A1CA2CA1
SCHEMBL28900119 0.86 RARB (0.64) RARBHSD17B10TSHRALDH1A1MEN1
SCHEMBL9633161 0.84 LPL (0.46) HSD17B10ALDH1A1CA2CA1HPGD
SCHEMBL16744188 0.83 CYP1A2 (0.46) RARBHSD17B10TSHRHRH3NPC1
SCHEMBL28569016 0.83 RARB (0.56) RARBHSD17B10TSHRALDH1A1MEN1
SCHEMBL23319637 0.82 RARB (0.60) RARBHSD17B10TSHRALDH1A1MEN1
SCHEMBL7513802 0.82 RARB (0.60) RARBHSD17B10TSHRALDH1A1MEN1
SCHEMBL10379965 0.81 RARB (0.68) RARBHSD17B10TSHRALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed